All in this together: collaboration in emergency prehospital care research – 29 & 30 March 2022

The 999 EMS Research Forum is a UK based partnership that bring together academics and health-care providers. The 2022 999 EMS Research Forum conference is hosted by Yorkshire Ambulance Service NHS Trust (YAS) in association with Yorkshire Ambulance Service Charity, and the National Ambulance Research Steering Group (NARSG). This will take place online on 29 Read more about All in this together: collaboration in emergency prehospital care research – 29 & 30 March 2022[…]

GoodSAM

GoodSAM (Smartphone Activated Medics) is an internationally recognised system which integrates a highly advanced emergency dispatching platform with an extensive network of trained first responders. The GoodSAM app works by sending an alert to all registered first-responders within a certain distance of patients having a suspected cardiac arrest. This allows registered volunteers to perform cardiopulmonary resuscitation (CPR) Read more about GoodSAM[…]

Airways 2

  AIRWAYS-2 was a randomised trial comparing the clinical and cost effectiveness of the i-gel supraglottic airway device with tracheal intubation in the initial airway management of patients who have suffered an out of hospital cardiac arrest (OHCA). The primary results of study have now been published here Participating Ambulance Services: East of England Ambulance Read more about Airways 2[…]

PARAMEDIC2 Almetric Score

A Randomised Trial of Epinephrine in Out-of-Hospital Cardiac Arrest This study involving five UK ambulance services and 8014 patients investigated whether using epinephrine for out-of-hospital cardiac arrest is safe and effective.  They found that using epinephrine led to improved 30-day survival compared with a placebo.  Altmetric tracks millions of mentions of 2.8 million research outputs, Read more about PARAMEDIC2 Almetric Score[…]

RIGHT-2

This randomised control trial sponsored by the British Heart Foundation assessed whether transdermal glyceryl trinitrate (GTN) is beneficial to patients experiencing a stroke. The trial completed recruitment in May 2018, and the results were published in February 2019 in The Lancet (RIGHT-2);┬áPre-hospital treatment with GTN for patients with presumed stroke does not appear to improve Read more about RIGHT-2[…]